HORAMA has established a pipeline of gene therapy candidates to treat rare ophthalmic diseases, including retinopathies and maculopathies.



Horama does not own any office in Australia.

The company was warned that someone, claiming to be Christine Placet or Christen Placet, had contacted australian job seekers.

If you see a job offer matching this description, do not answer.

Horama has filed a complaint.